GADD45α and annexin A1 are involved in the apoptosis of HL-60 induced by resveratrol

Phytomedicine

Volumn 18, Issue 8-9, 2011, Pages 704-709

  Li, Guanwu ^a   He, Shunhua ^b   Chang, Lijun ^a   Lu, Hong ^a   Zhang, Hongwei ^a   Zhang, Hao ^a   Chiu, Jenfu ^a,c  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b Haining People's Hospital   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Annexin A1; Apoptosis; GADD45 ; HL 60; Resveratrol

Indexed keywords

CASPASE 3; DNA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45 ALPHA; LIPOCORTIN 1; PROTEIN BAX; PROTEIN BCL 2; RESVERATROL; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL POPULATION; CELL PROLIFERATION; CELL STRAIN HL 60; CELL VIABILITY; CONTROLLED STUDY; DIPLOIDY; DNA DAMAGE; DNA SYNTHESIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANNEXIN A1; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; CELL CYCLE PROTEINS; CELL GROWTH PROCESSES; CELL SURVIVAL; DNA DAMAGE; G0 PHASE; G1 PHASE; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; NUCLEAR PROTEINS; NUCLEIC ACID SYNTHESIS INHIBITORS; STILBENES;

EID: 79958120468     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2010.11.015     Document Type: Article

References (36)

1. Alldridge, L.C., Bryant, C.E., 2003. Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Experimental Cell Research 290, 93-107. (Pubitemid 37153254)
2. Alldridge, L.C., Harris, H.J., Plevin, R., Hannon, R., Bryant, C.E., 1999. The annexin protein lipocortin 1 regulates the MAPK/ERK pathway. The Journal of Biological Chemistry 274, 37620-37628. (Pubitemid 30026818)
3. Banerjee, S., Bueso-Ramos, C., Aggarwal, B.B., 2002. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Research 62, 4945-4954. (Pubitemid 34984418)
4. Carrier, F., Georgel, P.T., Pourquier, P., Blake, M., Kontny, H.U., Antinore, M.J., Gariboldi, M., Myers, T.G., Weinstein, J.N., Pommier Jr., Y.A.J.F., 1999. Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin. Molecular and Cellular Biology 19, 1673-1685. (Pubitemid 29098226)
5. Chang, T.K., Chen, J., Lee, W.B., 2001. Differential inhibition and inactivation ofhuman CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2. The Journal of Pharmacology and Experimental Therapeutics 299, 874-882. (Pubitemid 33104954)
6. Chen, Z.H., Hurh, Y.J., Na, H.K., Kim, J.H., Chun, Y.J., Kim, D.H., Kang, K.S., Cho, M.H., Surh1, Y.J., 2004. Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells. Carcinogenesis 25, 2005-2013.
7. Ciolino, H.P., Daschner, P.J., Yeh, G.C., 1998. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Research 58, 5707-5712. (Pubitemid 29006410)
8. Debret, R., El Btaouri, H., Duca, L., Rahman, I., Radke, S., Haye, B., Sallenave, J.M., Antonicelli, F., 2003. Annexin A1 processing is associated with caspase-dependent apoptosis in BZR cells. FEBS Letters 546, 195-202. (Pubitemid 36782410)
9. Fontecave, M., Lepoivre, M., Elleingand, E., Gerez, C., Guittet, O., 1998. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Letters 421, 277-279. (Pubitemid 28045770)
10. Harkin, D.P., Bean, J.M., Miklos, D., Song, Y.H., Truong, V.B., Englert, C., Christians, F.C., Ellisen, L.W., Maheswaran, S., Oliner, J.D., Haber, D.A., 1999. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97, 575-586. (Pubitemid 29256961)
11. Hoffman, B., Liebermann, D.A., 2007. Role of gadd45 in myeloid cells in response to hematopoietic stress. Blood Cells, Molecules, and Diseases 39, 344-347. (Pubitemid 47484475)
12. Hollander, M.C., Alamo, I., Jackman, J., Wang, M.G., McBride Jr., O.W.A.J.F., 1993. Analysis of the mammalian gadd45 gene and its response to DNA damage. The Journal of Biological Chemistry 268, 24385-24393.
13. Hollander, M.C., Sheikh, M.S., Bulavin, D.V., Lundgren, K., Augeri-Henmueller, L., Shehee, R., Molinaro1, T.A., Kim, K.E., Tolosa, E., Ashwell, J.D., Rosenberg, M.P., Zhan, Q., Fernández-Salguero, P.M., Morgan, W.F., Deng, C.X., Fornace Jr1, A.J., 1999. Genomic instability in Gadd45α-deficient mice. Nature Genetics 23, 176-184.
14. Kastan, M.B., Zhan, Q., EL-Deiry, W.S., Carrier, F., Jacks, T., Walsh, W.V., Plunkett, B.S., Vogelstein Jr., B., 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia- telangiectasia. Cell 71, 587-597.
15. Kotha, A., Sekharam, M., Cilenti, L., Siddiquee, K., Khaled, A., Zervos, A.S., Carter, B., Turkson, J., Jove, R., 2006. Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Molecular Cancer Therapeutics 5, 621-629.
16. Liebermann, D.A., Hoffman, B., 2002. Myeloid differentiation (MyD)/Growth Arrest DNA Damage (GADD) genes in tumor suppression, immunity and inflammation. Leukemia 16, 527-541. (Pubitemid 34449730)
17. Lim, L.H., Pervaiz, S., 2007. Annexin 1: the new face of an old molecule. The FASEB Journal 21, 968-975. (Pubitemid 46495688)
18. Lin, M.T., Yen, M.L., Lin, C.Y., Kuo, M.L., 2003. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Molecular Pharmacology 64, 1029-1036.
19. Li, X.Q., Ding, X.Z., Adrian, T.E., 2004. Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells. Cancer Investigation 22, 389-400. (Pubitemid 39310909)
20. Lu, F., Zahid, M., Wang, C., Saeed, M., Cavalieri, E.L., Rogan, E.G., 2008. Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells. Cancer Prevention Research 1, 135-145.
21. Nguyen, T.H., Mustafa, F.B., Pervaiz, S., Ng, F.S., Lim, L.H., 2008. ERK1/2 activation is required for resveratrol-induced apoptosis in MDA-MB-231 cells. International Journal of Oncology 33, 81-92.
22. Pan, M.H., Chang, Y.H., Badmaev, V., Nagabhushanam, K., Ho, C.T., 2007. Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells. Journal of Agricultural and Food Chemistry 55, 7777-7785. (Pubitemid 47522187)
23. Pervaiz, S., 2004. Chemotherapeutic potential of the chemopreventive phytoalexin resveratrol. Drug Resistance Updates 7, 333-344. (Pubitemid 40341955)
24. Renaud, S., de Lorgeril, M., 1992. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 1523-1526.
25. Roman, V., Billard, C., Kern, C., Ferry-Dumazet, H., Izard, J.C., Mohammad, R., Mossalayi, D.M., Kolb, J.P., 2002. Analysis of resveratro1-induced apoptosis in human B-cell chronic leukemia. British Journal of Haematology 117, 842-851. (Pubitemid 34639245)
26. She, Q.B., Huang, C., Zhang, Y., Dong, Z., 2002. Involvement of c-jun NH(2)-terminal kinases in resveratrol-induced activation of p53 and apoptosis. Molecular Carcinogenesis 33, 244-250. (Pubitemid 34297132)
27. She, Q.B., Bode, A.M., Ma,W.Y., Chen, N.Y., Dong, Z., 2001. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Research 61, 1604-1610. (Pubitemid 34292594)
28. Smith, M.L., Ford, J.M., Hollander, M.C., Bortnick, R.A., Amundson, S.A., Seo, Y.R., Deng, C.X., Hanawalt Jr., P.C.A.J.F., 2000. p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or gadd45 genes. Molecular and Cellular Biology 20, 3705-3714. (Pubitemid 30243916)
29. Solito, E., de Coupade, C., Canaider, S., Goulding, N.J., Perretti, M., 2001. Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. British Journal of Pharmacology 133, 217-228. (Pubitemid 32514504)
30. Stewart, J.R., O'Brian, C.A., 2004. Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKC alpha inhibition. Investigational New Drugs 22, 107-117. (Pubitemid 38270466)
31. Wang, X.W., Zhan, Q., Coursen, J.D., Khan, M.A., Kontny, H.U., Yu, L.J., Hollander, M.C., O'Connor Jr., P.M., Harris, A.J.F.C.C., 1999. GADD45 induction of a G2/M cell cycle checkpoint. Proceedings of the National Academy of Sciences of the United States of America 96, 3706-3711. (Pubitemid 29168974)
32. Wink, M., 2008. Evolutionary advantage and molecular modes of action of multi-component mixtures used in phytomedicine. Current Drug Metabolism 9, 996-1009.
33. Zhan, Q., Lord, K.A., Alamo I.Jr., Hollander, M.C., Carrier, F., Ron, D., Kohn, K.W., Hoffman, B., Liebermann, D.A., Fornace A.J.Jr., 1994. The gadd and MyD genes define a novel set of mannalian genes encoding acidic proteins that synergistically suppress cell growth. Molecular and Cellular Biology 14, 2361-2371. (Pubitemid 24108218)
34. Zhang, D.Y., Song, L., Li, J.X.,Wu,K.J., Huang, C.S., 2006. Coordination of JNK1 and JNK2 is critical for GADD45α induction and its mediated cell apoptosis in arsenite responses. The Journal of Biological Chemistry 281, 34113-34123. (Pubitemid 46036620)
35. Zhou, H.B., Yan, Y., Sun, Y.N., Zhu, J.R., 2003. Resveratrol induces apoptosis in human esophageal carcinoma cells. World Journal of Gastroenterology 9, 408-411. (Pubitemid 36372096)
36. Zunino, S.J., Storms, D.H., 2006. Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore. Cancer Letters 240, 123-134. (Pubitemid 44037172)